Myriad Genetics

MYGN

NASDAQHealth Care

Income Statement

Total Revenue$837.6M

Gross Profit$585.4M

Operating Income$-123.4M

EBITDA$-49.9M

EBIT$-120.6M

Pre-tax Income$-399.8M

Net Income$-127.3M

Cash Equivalent$97.9M

Total Debt$143.38M

Book Value$733.33M

Book Value Per Share8.10

Return on Equity (ROE)-18.16%

Return on Assets (ROA)-12.39%

Return on Invested Capital (ROI)-17.19%

Net Profit Margin-15.20%

Current Ratio1.82

Quick Ratio1.42

Long-Term Debt / Equity0.06